Education
About Us
Working with TipRanks
Follow Us
Mind Medicine Inc. (DE:MMQ)
:MMQ
Total Valuation
Mind Medicine has a market cap or net worth of €1.04B. The enterprise value is €843.91M.
Market Cap€1.04B
Enterprise Value€843.91M
Share Statistics
Mind Medicine has 98,509,280 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding98,509,280
Owned by Insiders1.72%
Owned by Institutions18.51%
Financial Efficiency
Mind Medicine’s return on equity (ROE) is -0.45 and return on invested capital (ROIC) is -39.47%.
Return on Equity (ROE)-0.45
Return on Assets (ROA)-0.36
Return on Invested Capital (ROIC)-39.47%
Return on Capital Employed (ROCE)-0.39
Revenue Per Employee0.00
Profits Per Employee-1.47M
Employee Count74
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Mind Medicine is ―. Mind Medicine’s PEG ratio is 0.12.
PE Ratio―
PS Ratio0.00
PB Ratio2.03
Price to Fair Value2.03
Price to FCF-6.20
Price to Operating Cash Flow-12.53
PEG Ratio0.12
Income Statement
In the last 12 months, Mind Medicine had revenue of 0.00 and earned -108.68M in profits. Earnings per share was -1.54.
Revenue0.00
Gross Profit-527.00K
Operating Income-103.92M
Pretax Income-108.68M
Net Income-108.68M
EBITDA-105.87M
Earnings Per Share (EPS)-1.54
Cash Flow
In the last 12 months, operating cash flow was -84.37M and capital expenditures 0.00, giving a free cash flow of -84.37M billion.
Operating Cash Flow-84.37M
Free Cash Flow-84.37M
Free Cash Flow per Share-0.86
Dividends & Yields
Mind Medicine pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.39
52-Week Price Change54.59%
50-Day Moving Average10.52
200-Day Moving Average7.70
Relative Strength Index (RSI)51.61
Average Volume (3m)254.00
Important Dates
Mind Medicine upcoming earnings date is Mar 5, 2026, Before Open (Confirmed).
Last Earnings DateNov 6, 2025
Next Earnings DateMar 5, 2026
Ex-Dividend Date―
Financial Position
Mind Medicine as a current ratio of 7.25, with Debt / Equity ratio of 0.00%
Current Ratio7.25
Quick Ratio7.25
Debt to Market Cap0.04
Net Debt to EBITDA2.38
Interest Coverage Ratio-45.52
Taxes
In the past 12 months, Mind Medicine has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Mind Medicine EV to EBITDA ratio is -2.25, with an EV/FCF ratio of -3.01.
EV to Sales0.00
EV to EBITDA-2.25
EV to Free Cash Flow-3.01
EV to Operating Cash Flow-3.01
Balance Sheet
Mind Medicine has €209.07M in cash and marketable securities with €0.00 in debt, giving a net cash position of €209.07M billion.
Cash & Marketable Securities€209.07M
Total Debt€0.00
Net Cash€209.07M
Net Cash Per Share€2.12
Tangible Book Value Per Share€3.14
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Mind Medicine is €24.07, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target€24.07
Price Target Upside130.37% Upside
Analyst ConsensusStrong Buy
Analyst Count8
Revenue Growth Forecast―
EPS Growth Forecast―